#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epstein-Barr virus associated lymphoproliferative disorder T-cell lymphoma Anal squamous cell carcinoma Head and neck cancer Myxoid liposarcoma Human papilloma virus immunisation Mantle cell lymphoma stage III Systemic lupus erythematosus Chronic granulomatous disease Brain abscess Mantle cell lymphoma refractory Chemical burn Thyroid cancer metastatic Osteochondrodysplasia Acquired haemophilia More trials…

    Learn about Rare Diseases

    Factor IX deficiency – Diagnostics Haemophagocytic lymphohistiocytosis – Basic Information Turner’s syndrome – Basic Information Ornithine transcarbamoylase deficiency – Basic Information Lennox-Gastaut syndrome – Trials in Disease Focal segmental glomerulosclerosis – Trials in Disease Congenital hypotransferrinaemia – Life with Disease Antithrombin III deficiency – Life with Disease Noonan syndrome – Diagnostics Mucopolysaccharidosis III – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tamsulosin Hydrochloride Ethambutol Barzolvolimab Sodium Nitrite Ursodeoxycholic Acid Flutafuranol (18F) Pemetrexed Diacid Monohydrate SEVABERTINIB T89 Vgl101 Florbetapir (18F) Pd01B Sulfur Hexafluoride Valoctocogene Roxaparvovec Erdafitinib Mepolizumab Demeclocycline Hydrochloride Pregabalin Fampridine Sisunatovir More therapies…

    Learn about Your Condition

    Body mass index increased Substance use disorder H1N1 influenza Bacterial vaginosis Tardive dyskinesia Skin candida Abdominal wall pain Hand fracture Cerebrovascular accident Decreased appetite Streptococcal infection Hairy cell leukaemia Shock B-cell lymphoma refractory Paraesthesia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Gout

  • Study of Dapansutrile and Paracetamol for Patients with Acute Gout Flare

    Recruiting

    4 1 1
    Investigated Drugs:
    • Dapansutrile
    • Paracetamol
    France The Netherlands Spain

  • Study on Stopping Allopurinol or Febuxostat in Gout Patients in Remission

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Allopurinol
    • Febuxostat
    France

  • Study on Gout: Comparing Immediate vs. Delayed Use of Febuxostat for Patients with Acute Gout Attacks

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Gout
    Investigated Drugs:
    • Febuxostat
    France

  • Study on Treating Acute Gout Attacks with Prednisolone and Colchicine for Primary Care Patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Colchicine
    • Prednisolone
    Germany

  • Study on Gout Treatment: Comparing Allopurinol, Benzbromarone, and Febuxostat in Patients with Gout in Remission

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Gouty arthritis
    • Gout
    Investigated Drugs:
    • Febuxostat Hemihydrate
    • Allopurinol
    The Netherlands

  • Study on the Effects of Tigulixostat and Allopurinol in Patients with Gout and High Uric Acid Levels

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Autumn Crocus Fresh Flower Fluid Extract (1:15-25), Extraction Solvent Ethanol 96% (V/V)
    • Tigulixostat
    • Allopurinol
    Belgium Bulgaria Czechia France Germany Italy +3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!